Breakthrough Nucleic Acid Therapeutics by QTsomeTM Technology. 

Advances in medical technology and our understanding of biology have paved the way for the treatment diseases once thought incurable. Delivery of drug to the correct site of therapeutic action while minimizing off-target exposure is paramount to achieving safe and effective therapy. WGI overcomes delivery challenges in complex diseases including oncology through strategic application of nanotechnology.

Biotechnology

Life Sciences

Nanotechnology

Pharmaceutical

The Whiteoak Group

The Whiteoak Group's headquarters in Washington, United States

Description

People (1)

Jobs (0)

Other offices